Replication-incompetent influenza A viruses that stably express a foreign gene

References

1. Davies W. L., Grunert R. R., Haff R. F., McGahen J. W., Neumayer E. M., Paulshock M., Watts J. C., Wood T. R., Hermann E. C., Hoffmann C. E. 1964; Antiviral activity of 1-adamantanamine (amantadine). Science 144:862–863 [View Article][PubMed]
   [Google Scholar]
2. DuBridge R. B., Tang P., Hsia H. C., Leong P.-M., Miller J. H., Calos M. P. 1987; Analysis of mutation in human cells by using an Epstein–Barr virus shuttle system. Mol Cell Biol 7:379–387[PubMed]
   [Google Scholar]
3. Hatakeyama S., Sakai-Tagawa Y., Kiso M., Goto H., Kawakami C., Mitamura K., Sugaya N., Suzuki Y., Kawaoka Y. 2005; Enhanced expression of an α2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor. J Clin Microbiol 43:4139–4146 [View Article][PubMed]
   [Google Scholar]
4. Hatta M., Asano Y., Masunaga K., Ito T., Okazaki K., Toyoda T., Kawaoka Y., Ishihama A., Kida H. 2000; Mapping of functional domains on the influenza A virus RNA polymerase PB2 molecule using monoclonal antibodies. Arch Virol 145:1947–1961 [View Article][PubMed]
   [Google Scholar]
5. Hayden F. G. 2001; Perspectives on antiviral use during pandemic influenza. Philos Trans R Soc Lond B Biol Sci 356:1877–1884 [View Article][PubMed]
   [Google Scholar]
6. Horimoto T., Murakami S., Muramoto Y., Yamada S., Fujii K., Kiso M., Iwatsuki-Horimoto K., Kino Y., Kawaoka Y. 2007; Enhanced growth of seed viruses for H5N1 influenza vaccines. Virology 366:23–27 [View Article][PubMed]
   [Google Scholar]
7. Hossain M. J., Perez S., Guo Z., Chen L.-M., Donis R. O. 2010; Establishment and characterization of a Madin–Darby canine kidney reporter cell line for influenza A virus assays. J Clin Microbiol 48:2515–2523 [View Article][PubMed]
   [Google Scholar]
8. Itoh Y., Shinya K., Kiso M., Watanabe T., Sakoda Y., Hatta M., Muramoto Y., Tamura D., Sakai-Tagawa Y. et al.& other authors ( 2009; In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460:1021–1025[PubMed]
   [Google Scholar]
9. Kobasa D., Takada A., Shinya K., Hatta M., Halfmann P., Theriault S., Suzuki H., Nishimura H., Mitamura K. et al.& other authors ( 2004; Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature 431:703–707 [View Article][PubMed]
   [Google Scholar]
10. Kong W.-P., Hood C., Yang Z.-Y., Wei C.-J., Xu L., García-Sastre A., Tumpey T. M., Nabel G. J. 2006; Protective immunity to lethal challenge of the 1918 pandemic influenza virus by vaccination. Proc Natl Acad Sci U S A 103:15987–15991 [View Article][PubMed]
    [Google Scholar]
11. Li Y., Larrimer A., Curtiss T., Kim J., Jones A., Baird-Tomlinson H., Pekosz A., Olivo P. D. 2009; Influenza virus assays based on virus-inducible reporter cell lines. Influenza Other Respir Viruses 3:241–251 [View Article][PubMed]
    [Google Scholar]
12. Li F., Feng L., Pan W., Dong Z., Li C., Sun C., Chen L. 2010; Generation of replication-competent recombinant influenza A viruses carrying a reporter gene harbored in the neuraminidase segment. J Virol 84:12075–12081 [View Article][PubMed]
    [Google Scholar]
13. Manicassamy B., Manicassamy S., Belicha-Villanueva A., Pisanelli G., Pulendran B., García-Sastre A. 2010; Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc Natl Acad Sci U S A 107:11531–11536 [View Article][PubMed]
    [Google Scholar]
14. Martínez-Sobrido L., Cadagan R., Steel J., Basler C. F., Palese P., Moran T. M., García-Sastre A. 2010; Hemagglutinin-pseudotyped green fluorescent protein-expressing influenza viruses for the detection of influenza virus neutralizing antibodies. J Virol 84:2157–2163 [View Article][PubMed]
    [Google Scholar]
15. Muramoto Y., Takada A., Fujii K., Noda T., Iwatsuki-Horimoto K., Watanabe S., Horimoto T., Kida H., Kawaoka Y. 2006; Hierarchy among viral RNA (vRNA) segments in their role in vRNA incorporation into influenza A virions. J Virol 80:2318–2325 [View Article][PubMed]
    [Google Scholar]
16. Nayak B., Kumar S., DiNapoli J. M., Paldurai A., Perez D. R., Collins P. L., Samal S. K. 2010; Contributions of the avian influenza virus HA, NA, and M2 surface proteins to the induction of neutralizing antibodies and protective immunity. J Virol 84:2408–2420 [View Article][PubMed]
    [Google Scholar]
17. Neumann G., Watanabe T., Ito H., Watanabe S., Goto H., Gao P., Hughes M., Perez D. R., Donis R. et al.& other authors ( 1999; Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci U S A 96:9345–9350 [View Article][PubMed]
    [Google Scholar]
18. Niwa H., Yamamura K., Miyazaki J. 1991; Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193–199 [View Article][PubMed]
    [Google Scholar]
19. Palese P., Shaw M. L. 2007; Orthomyxoviridae: the viruses and their replication. In Fields Virology, 5th edn. pp. 1647–1689 Edited by Knipe D. M., Howley P. M. Philadelphia, PA: Lippincott Williams & Wilkins;
    [Google Scholar]
20. Rimmelzwaan G. F., Verburgh R. J., Nieuwkoop N. J., Bestebroer T. M., Fouchier R. A., Osterhaus A. D. 2011; Use of GFP-expressing influenza viruses for the detection of influenza virus A/H5N1 neutralizing antibodies. Vaccine 29:3424–3430 [View Article][PubMed]
    [Google Scholar]
21. Watanabe S., Watanabe T., Kawaoka Y. 2009; Influenza A virus lacking M2 protein as a live attenuated vaccine. J Virol 83:5947–5950 [View Article][PubMed]
    [Google Scholar]
22. Wright P. F., Neumann G., Kawaoka Y. 2007; Orthomyxoviruses. In Fields Virology, 5th edn. pp. 1691–1740 Edited by Knipe D. M., Howley P. M. Philadelphia, PA: Lippincott Williams & Wilkins;
    [Google Scholar]
23. Yamada S., Hatta M., Staker B. L., Watanabe S., Imai M., Shinya K., Sakai-Tagawa Y., Ito M., Ozawa M. et al.& other authors ( 2010; Biological and structural characterization of a host-adapting amino acid in influenza virus. PLoS Pathog 6:e1001034 [View Article][PubMed]
    [Google Scholar]